跳至主要内容
临床试验/NCT05630963
NCT05630963招募中不适用

Beyond Monoamines: The Role of the Nociceptin/Orphanin FQ Receptor in Major Depression

Mclean Hospital1 个研究点 分布在 1 个国家目标入组 228 人开始时间: 2021年12月29日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
228
试验地点
1
主要终点
Salivary Cortisol

研究概览

简要总结

This study looks at the role of the Nociceptin/Orphanin FQ receptor system in the brain of individuals with current or past major depressive disorder (MDD). It also examines how individuals with a history of depression make certain decisions and which brain regions are involved in such decisions. Information collected through MRI, PET, biospecimens (i.e., blood, saliva) and behavioral tasks will be used to predict depressive symptoms in the future.

详细描述

The overarching goals of this research are to investigate: (1) the activity of the Nociceptin/Orphanin FQ receptor system among individuals with current or remitted MDD; (2) neural foundations of approach/avoidance behaviors in current or remitted MDDs; (3) stress-induced inflammation in individuals with remitted MDD; (4) neural markers that predict future disease course.

This will be achieved through an innovative method of using functional magnetic resonance imaging (fMRI) during an approach/avoidance decision-making task, in addition to a resting positron emission tomography (PET) scan.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

研究组 & 干预措施

MDD subjects

Subjects diagnosed with Major Depression Disorder

干预措施: Aversive stimuli (Device)

MDD subjects

Subjects diagnosed with Major Depression Disorder

干预措施: PET radiotracer (Drug)

Remitted MDD subjects

Subjects with a history of major depressive disorder episode in the past

干预措施: Aversive stimuli (Device)

Remitted MDD subjects

Subjects with a history of major depressive disorder episode in the past

干预措施: PET radiotracer (Drug)

Control subjects

Subjects with no history of known neurological and psychiatric illness.

干预措施: Aversive stimuli (Device)

Control subjects

Subjects with no history of known neurological and psychiatric illness.

干预措施: PET radiotracer (Drug)

结局指标

主要结局

Salivary Cortisol

时间窗: Baseline

For assessing stress level

Clinical Interview

时间窗: Baseline

For assessing psychological state

MRI Data

时间窗: within 30 days of Screening Visit

For testing the neural correlates of approach-avoidance decision making behaviors

PET Data

时间窗: within 30 days of Screening Visit

For assessing the Nociceptin/Oprhanin FQ receptor system activity

Follow-up Clinical Interviews

时间窗: Change from Baseline at 6 months and 12 months after the PET visit

To assess psychological state changes

Behavioral Performance on the Probabilistic Reward Task (PRT)

时间窗: Baseline

the PRT assesses individuals' ability to learn from rewards

Arterial blood data

时间窗: Baseline

for PET modeling and assessing Nociceptin/Orphanin FQ levels in bloodstream

次要结局

  • Childhood Trauma Questionnaire (CTQ)(Baseline)
  • Medical Outcome Survey-Short form (SF-36)(Change from Baseline at 6 months and 12 months after the PET visit)
  • Quality of Life Enjoyment and Satisfaction Questionnaire (Q-LES-Q)(Change from Baseline at 6 months and 12 months after the PET visit)
  • Snaith Hamilton Pleasure Scale (SHAPS)(Change from Baseline at 6 months and 12 months after the PET visit)
  • Thought and Feeling Questionnaire (TFQ)(Baseline)
  • Temporal Experience of Pleasure Scale (TEPS)(Change from Baseline at 6 months and 12 months after the PET visit)
  • Stress and Adversity Inventory (STRAIN)(Change from Baseline at 12 months after the PET visit)
  • Perceived Stress Scale (PSS)(Change from Baseline at 6 months and 12 months after the PET visit)
  • PRT Post-task Questionnaire(Baseline)
  • Columbia-Suicide Severity Rating Scale (C-SSRS)(Baseline)
  • Positive and Negative Affect Schedule (PANAS)(Baseline)
  • Hamilton-Depression Rating Scale (HAMD-17)(Change from Baseline at 6 months and 12 months after the PET visit)
  • Beck Depression Inventory-II (BDI)(Change from Baseline at 6 months and 12 months after the PET visit)
  • Mood and Anxiety Symptom Questionnaire (MASQ)(Baseline)
  • Cognitive-Behavioral Avoidance Scale (CBAS)(Baseline)
  • Defeat Scale (DS)(Baseline)
  • Questionnaire of Unpredictability in Childhood (QUIC)(Change from Baseline at 6 months and 12 months after the PET visit)
  • State-Trait Anxiety Inventory (STAI)(Baseline)
  • Quick Inventory of Depressive Symptomatology (QIDS)(Change from Baseline at 6 months and 12 months after the PET visit)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Diego Pizzagalli

Director, Center for Depression, Anxiety and Stress Research

Mclean Hospital

研究点 (1)

Loading locations...

相似试验

Beyond Monoamines: The Role of the... | 临床试验